- Home
- MDGL vs MNSO Comparison
MDGL vs MNSO Comparison
Compare MDGL & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MNSO
- Stock Information
- Founded
- MDGL 2011
- MNSO 2013
- Country
- MDGL United States
- MNSO China
- Employees
- MDGL N/A
- MNSO N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MNSO Department/Specialty Retail Stores
- Sector
- MDGL Health Care
- MNSO Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MNSO Nasdaq
- Market Cap
- MDGL 6.8B
- MNSO 6.5B
- IPO Year
- MDGL N/A
- MNSO 2020
- Fundamental
- Price
- MDGL $290.96
- MNSO $20.30
- Analyst Decision
- MDGL Strong Buy
- MNSO Buy
- Analyst Count
- MDGL 10
- MNSO 4
- Target Price
- MDGL $420.63
- MNSO $24.40
- AVG Volume (30 Days)
- MDGL 361.7K
- MNSO 939.3K
- Earning Date
- MDGL 05-01-2025
- MNSO 05-23-2025
- Dividend Yield
- MDGL N/A
- MNSO 2.91%
- EPS Growth
- MDGL N/A
- MNSO 16.73
- EPS
- MDGL N/A
- MNSO 1.15
- Revenue
- MDGL $317,383,000.00
- MNSO $2,328,235,670.00
- Revenue This Year
- MDGL $264.55
- MNSO $25.91
- Revenue Next Year
- MDGL $67.21
- MNSO $18.77
- P/E Ratio
- MDGL N/A
- MNSO $18.05
- Revenue Growth
- MDGL N/A
- MNSO 22.80
- 52 Week Low
- MDGL $200.08
- MNSO $12.51
- 52 Week High
- MDGL $377.46
- MNSO $27.71
- Technical
- Relative Strength Index (RSI)
- MDGL 40.85
- MNSO 60.94
- Support Level
- MDGL $280.00
- MNSO $19.51
- Resistance Level
- MDGL $307.54
- MNSO $20.92
- Average True Range (ATR)
- MDGL 15.97
- MNSO 0.62
- MACD
- MDGL -2.00
- MNSO 0.34
- Stochastic Oscillator
- MDGL 15.88
- MNSO 81.13
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.